Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGAL as Biomarker for Kidney Damage in PCI with Iopamidol or Iodixanol
NCT01137786Phase 4Completed
- Sponsor
- Bracco Diagnostics Inc.
- Start
- Dec 2010
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of iopamidol in coronary artery stenosis, sponsored by Bracco Diagnostics Inc.. Started Dec 2010; status: completed.
02
Drugs
iopamidol
03
Conditions
coronary artery stenosis
Beyond the preview
Go deeper on NCT01137786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01137786.